{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T04:11:14Z","timestamp":1779423074574,"version":"3.53.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,21]]},"DOI":"10.7759\/cureus.109399","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T04:03:42Z","timestamp":1779422622000},"source":"Crossref","is-referenced-by-count":0,"title":["Congenital Thrombotic Thrombocytopenic Purpura Presenting as Recurrent Ischemic Stroke in a Young Adult: A Genetically Confirmed Case"],"prefix":"10.7759","author":[{"given":"Rajashekar","family":"V","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukil","family":"Soundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthilpriyan","family":"K","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshaya Kumar","family":"Balagopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hema","family":"K","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vyas","family":"R","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santhi T","family":"S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Thrombotic thrombocytopenic purpura","author":"Stanley M","year":"2023","unstructured":"Stanley M, Killeen RB, Michalski JM. Thrombotic thrombocytopenic purpura. StatPearls. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-025-04542-0","article-title":"Spectrum and outcomes of thrombotic microangiopathies in nephrology: a 17-year cohort from a North African center","volume":"26","author":"Mrabet S","year":"2025","unstructured":"Mrabet S, Dardour G, Boukadida R, Emah S, Sahtout W, Zellama D. Spectrum and outcomes of thrombotic microangiopathies in nephrology: a 17-year cohort from a North African center. BMC Nephrol. 2025, 26:631. 10.1186\/s12882-025-04542-0","journal-title":"BMC Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura","volume":"129","author":"Joly BS","year":"2017","unstructured":"Joly BS, Coppo P, Veyradier A. Thrombotic thrombocytopenic purpura. Blood. 2017, 129:2836-46. 10.1182\/blood-2016-10-709857","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2025000759","article-title":"Modern management of congenital thrombotic thrombocytopenic purpura (cTTP)","volume":"2025","author":"Taylor A","year":"2025","unstructured":"Taylor A, Scully M. Modern management of congenital thrombotic thrombocytopenic purpura (cTTP). Hematology Am Soc Hematol Educ Program. 2025, 2025:628-35. 10.1182\/hematology.2025000759","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000031851","article-title":"Thrombotic thrombocytopenic purpura with neurological impairment: a Review","volume":"101","author":"Zhu H","year":"2022","unstructured":"Zhu H, Liu JY. Thrombotic thrombocytopenic purpura with neurological impairment: a Review. Medicine (Baltimore). 2022, 101:e31851. 10.1097\/MD.0000000000031851","journal-title":"Medicine (Baltimore)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505533","article-title":"Caplacizumab for acquired thrombotic thrombocytopenic purpura","volume":"374","author":"Peyvandi F","year":"2016","unstructured":"Peyvandi F, Scully M, Kremer Hovinga JA, et al.. Caplacizumab for acquired thrombotic thrombocytopenic purpura. N Engl J Med. 2016, 374:511-22. 10.1056\/NEJMoa1505533","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10030536","article-title":"Thrombotic thrombocytopenic purpura: pathophysiology, diagnosis, and management","volume":"10","author":"Sukumar S","year":"2021","unstructured":"Sukumar S, L\u00e4mmle B, Cataland SR. Thrombotic thrombocytopenic purpura: pathophysiology, diagnosis, and management. J Clin Med. 2021, 10:536. 10.3390\/jcm10030536","journal-title":"J Clin Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-061813-013241","article-title":"ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura","volume":"66","author":"Zheng XL","year":"2015","unstructured":"Zheng XL. ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura. Annu Rev Med. 2015, 66:211-25. 10.1146\/annurev-med-061813-013241","journal-title":"Annu Rev Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.07.017","article-title":"Immune-thrombotic thrombocytopenic purpura is a rare cause of ischemic stroke in young adults: case reports and literature review","volume":"27","author":"Tomich C","year":"2018","unstructured":"Tomich C, Debruxelles S, Delmas Y, et al.. Immune-thrombotic thrombocytopenic purpura is a rare cause of ischemic stroke in young adults: case reports and literature review. J Stroke Cerebrovasc Dis. 2018, 27:3163-71. 10.1016\/j.jstrokecerebrovasdis.2018.07.017","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12826","article-title":"Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity","volume":"13","author":"Zafrani L","year":"2015","unstructured":"Zafrani L, Mariotte E, Darmon M, et al.. Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity. J Thromb Haemost. 2015, 13:380-9. 10.1111\/jth.12826","journal-title":"J Thromb Haemost"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000153","article-title":"Treatment of immune-mediated cytopenias in patients with primary immunodeficiencies and immune regulatory disorders (PIRDs)","volume":"2020","author":"Seidel MG","year":"2020","unstructured":"Seidel MG. Treatment of immune-mediated cytopenias in patients with primary immunodeficiencies and immune regulatory disorders (PIRDs). Hematology Am Soc Hematol Educ Program. 2020, 2020:673-9. 10.1182\/hematology.2020000153","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(17)30026-1","article-title":"Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study","volume":"4","author":"Bendapudi PK","year":"2017","unstructured":"Bendapudi PK, Hurwitz S, Fry A, et al.. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study. Lancet Haematol. 2017, 4:e157-64. 10.1016\/S2352-3026(17)30026-1","journal-title":"Lancet Haematol"},{"key":"ref13","article-title":"Current management of thrombotic thrombocytopenic purpura","volume":"8","author":"Coppo P","year":"2002","unstructured":"Coppo P, Bussel A, Galicier L, Schlemmer B, Vernant JP. Current management of thrombotic thrombocytopenic purpura. Transfus Clin Biol. 2002, 8:52-60.","journal-title":"Transfus Clin Biol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15006","article-title":"ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura","volume":"18","author":"Zheng XL","year":"2020","unstructured":"Zheng XL, Vesely SK, Cataland SR, et al.. ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura. J Thromb Haemost. 2020, 18:2486-95. 10.1111\/jth.15006","journal-title":"J Thromb Haemost"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-06-724161","article-title":"Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura","volume":"128","author":"Page EE","year":"2016","unstructured":"Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN. Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura. Blood. 2016, 128:2175-8. 10.1182\/blood-2016-06-724161","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/485596-congenital-thrombotic-thrombocytopenic-purpura-presenting-as-recurrent-ischemic-stroke-in-a-young-adult-a-genetically-confirmed-case","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T04:03:48Z","timestamp":1779422628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/485596-congenital-thrombotic-thrombocytopenic-purpura-presenting-as-recurrent-ischemic-stroke-in-a-young-adult-a-genetically-confirmed-case"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.109399","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,21]]}}}